Rmr Wealth Builders Uni Qure N.V. Transaction History

Rmr Wealth Builders

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$29.97 - $37.17 $41,268 - $51,183	-1,377 Closed	0 $0
Q4 2020 Feb 26, 2021	BUY	$35.35 - $50.67 $48,676 - $69,772	1,377 New	1,377 $50,000
Q3 2020 Nov 13, 2020	SELL	$35.98 - $47.66 $44,543 - $59,003	-1,238 Closed	0 $0
Q4 2019 Mar 03, 2020	BUY	$37.13 - $74.62 $45,966 - $92,379	1,238 New	1,238 $89,000

142

35.3M

1.54M

389K

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $300M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

Get notified when there are updates to the investment portfolio of Rmr Wealth Builders, based on Form 13F filings with the SEC.

Stay updated on Rmr Wealth Builders with notifications on news.